Stock A119610 INTEROJO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Interojo Inc.

Equities

A119610

KR7119610004

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 04/04/2024 BST 		5-day change 1st Jan Change
24,900 KRW -15.74% Intraday chart for Interojo Inc. -.--% -21.20%
05-16 Interojo Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-15 Interojo Inc.(KOSDAQ:A119610) dropped from S&P Global BMI Index CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The company returns high margins, thereby supporting business profitability.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Its low valuation, with P/E ratio at 8.71 and 7.23 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Analyst opinion has improved significantly over the past four months.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
INTEROJO INC. Stock Interojo Inc.
-21.20% 226M -
ALCON INC. Stock Alcon Inc.
+21.91% 44.08B
B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-9.21% 17.1B
B-
AUTEK CHINA INC. Stock Autek China Inc.
-31.67% 1.9B
D+
WARBY PARKER INC. Stock Warby Parker Inc.
+11.49% 1.87B
C+
PEGAVISION CORPORATION Stock Pegavision Corporation
+8.70% 1.04B -
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-8.84% 659M -
SHANGHAI CONANT OPTICAL CO., LTD. Stock Shanghai Conant Optical Co., Ltd.
+64.31% 633M - -
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-45.94% 625M -
MENICON CO., LTD. Stock Menicon Co., Ltd.
-44.70% 616M
B-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. A119610 Stock
  4. Ratings Interojo Inc.